Drug recall D-1185-2014
Product
Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13
Reason for recall
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
Lots and codes
Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
Recall details
- Recalling firm
- Viiv Healthcare Company, Durham, NC
- Quantity
- 1,056 bottles
- Distribution
- Nationwide including Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 11, 2014
- Terminated
- August 21, 2014
Related products
- Tivicay – drug information
- NDC 49702-255 Tivicay PD · Dolutegravir Sodium 5 mg/1 · ViiV Healthcare Company
- NDC 49702-227 Tivicay · Dolutegravir Sodium 25 mg/1 · ViiV Healthcare Company
- NDC 49702-228 Tivicay · Dolutegravir Sodium 50 mg/1 · ViiV Healthcare Company
- NDC 49702-226 Tivicay · Dolutegravir Sodium 10 mg/1 · ViiV Healthcare Company